HK1219231A1 - 治療兒童實體瘤的方法 - Google Patents
治療兒童實體瘤的方法Info
- Publication number
- HK1219231A1 HK1219231A1 HK16107309.3A HK16107309A HK1219231A1 HK 1219231 A1 HK1219231 A1 HK 1219231A1 HK 16107309 A HK16107309 A HK 16107309A HK 1219231 A1 HK1219231 A1 HK 1219231A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- treatment
- methods
- solid tumor
- pediatric solid
- pediatric
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5052—Proteins, e.g. albumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Ophthalmology & Optometry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361780658P | 2013-03-13 | 2013-03-13 | |
US201361805817P | 2013-03-27 | 2013-03-27 | |
US201361829940P | 2013-05-31 | 2013-05-31 | |
US201361909868P | 2013-11-27 | 2013-11-27 | |
PCT/US2014/022541 WO2014143613A1 (en) | 2013-03-13 | 2014-03-10 | Methods of treatment of pediatric solid tumor |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1219231A1 true HK1219231A1 (zh) | 2017-03-31 |
Family
ID=51537501
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16107309.3A HK1219231A1 (zh) | 2013-03-13 | 2016-06-23 | 治療兒童實體瘤的方法 |
Country Status (12)
Country | Link |
---|---|
US (1) | US20160015817A1 (zh) |
EP (1) | EP2968253A4 (zh) |
JP (3) | JP6387389B2 (zh) |
KR (1) | KR20150126671A (zh) |
CN (1) | CN105209035A (zh) |
AU (2) | AU2014228386B2 (zh) |
CA (1) | CA2903470A1 (zh) |
HK (1) | HK1219231A1 (zh) |
IL (1) | IL240987A0 (zh) |
MX (1) | MX2015011783A (zh) |
NZ (1) | NZ630367A (zh) |
WO (1) | WO2014143613A1 (zh) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
PT2117520T (pt) | 2006-12-14 | 2018-12-04 | Abraxis Bioscience Llc | Terapia do cancro da mama com base no estado do receptor do hormona com nanoparticulas compreendendo taxane |
US20100297243A1 (en) | 2009-04-15 | 2010-11-25 | Desai Neil P | Prion free nanoparticle compositions and methods of making thereof |
KR20130028727A (ko) | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
LT2552415T (lt) | 2010-03-29 | 2016-12-27 | Abraxis Bioscience, Llc | Vėžio gydymo būdai |
RU2576609C2 (ru) | 2010-06-04 | 2016-03-10 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечение рака поджелудочной железы |
JP6038123B2 (ja) | 2011-04-28 | 2016-12-07 | アブラクシス バイオサイエンス, エルエルシー | ナノ粒子組成物の脈管内送達およびそれらの使用 |
SI2790675T1 (sl) | 2011-12-14 | 2019-11-29 | Abraxis Bioscience Llc | Uporaba polimernih pomožnih snovi za liofilizacijo ali zamrzovanje delcev |
US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
CN105228612A (zh) | 2013-03-12 | 2016-01-06 | 阿布拉科斯生物科学有限公司 | 治疗肺癌的方法 |
RU2015143490A (ru) | 2013-03-14 | 2017-04-26 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения рака мочевого пузыря |
US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
EA202092187A1 (ru) | 2015-06-29 | 2021-08-31 | АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи | Способы лечения эпителиоидно-клеточных опухолей |
JP2021528362A (ja) | 2018-03-20 | 2021-10-21 | アブラクシス バイオサイエンス, エルエルシー | mTOR阻害剤およびアルブミンのナノ粒子の投与を介して中枢神経系障害を処置する方法 |
CN115003284A (zh) | 2019-10-28 | 2022-09-02 | 阿布拉科斯生物科学有限公司 | 白蛋白和雷帕霉素的药物组合物 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
CN1101700C (zh) * | 1997-12-05 | 2003-02-19 | 上海众联生化技术开发有限公司 | 多肽口服液 |
ITMI20001107A1 (it) * | 2000-05-18 | 2001-11-18 | Acs Dobfar Spa | Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel |
SI1585548T1 (sl) | 2002-12-09 | 2018-11-30 | Abraxis Bioscience, Llc | Sestave in metode odmerjanja farmakoloških sredstev |
CN1261161C (zh) * | 2003-11-10 | 2006-06-28 | 钱汶光 | 复方干扰素诱生剂口含片 |
SI3248600T1 (sl) | 2005-02-18 | 2020-09-30 | Abraxis Bioscience, Llc | Kombinacije in načini dajanja terapevtskih sredstev in kombinacijska terapija |
CN101291658B (zh) | 2005-08-31 | 2014-04-16 | 阿布拉科斯生物科学有限公司 | 用于制备稳定性增加的水难溶性药物的组合物和方法 |
WO2008137148A2 (en) | 2007-05-03 | 2008-11-13 | Abraxis Bioscience, Llc | Methods and compositions for treating pulmonary hypertension |
CA2781300A1 (en) * | 2009-11-20 | 2011-05-26 | Infinity Pharmaceuticals, Inc. | Methods and compositions for treating hedgehog-associated cancers |
KR20130028727A (ko) * | 2010-03-29 | 2013-03-19 | 아브락시스 바이오사이언스, 엘엘씨 | 치료제의 약물 전달 및 유효성 향상 방법 |
BR112012030699A2 (pt) * | 2010-06-02 | 2016-09-13 | Abraxis Bioscience Llc | métodos para tratar câncer de bexiga |
-
2014
- 2014-03-10 JP JP2016500995A patent/JP6387389B2/ja active Active
- 2014-03-10 NZ NZ630367A patent/NZ630367A/en unknown
- 2014-03-10 CA CA2903470A patent/CA2903470A1/en not_active Abandoned
- 2014-03-10 US US14/771,783 patent/US20160015817A1/en not_active Abandoned
- 2014-03-10 CN CN201480026752.3A patent/CN105209035A/zh active Pending
- 2014-03-10 EP EP14763546.0A patent/EP2968253A4/en not_active Withdrawn
- 2014-03-10 KR KR1020157027992A patent/KR20150126671A/ko not_active Application Discontinuation
- 2014-03-10 WO PCT/US2014/022541 patent/WO2014143613A1/en active Application Filing
- 2014-03-10 AU AU2014228386A patent/AU2014228386B2/en not_active Ceased
- 2014-03-10 MX MX2015011783A patent/MX2015011783A/es unknown
-
2015
- 2015-09-01 IL IL240987A patent/IL240987A0/en unknown
-
2016
- 2016-06-23 HK HK16107309.3A patent/HK1219231A1/zh unknown
-
2018
- 2018-01-24 JP JP2018009402A patent/JP2018062528A/ja not_active Withdrawn
-
2019
- 2019-02-27 AU AU2019201357A patent/AU2019201357A1/en not_active Abandoned
- 2019-07-03 JP JP2019124315A patent/JP2019163334A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2014228386B2 (en) | 2018-11-29 |
AU2014228386A1 (en) | 2015-09-24 |
JP2016512513A (ja) | 2016-04-28 |
CN105209035A (zh) | 2015-12-30 |
JP2019163334A (ja) | 2019-09-26 |
AU2019201357A1 (en) | 2019-03-21 |
US20160015817A1 (en) | 2016-01-21 |
CA2903470A1 (en) | 2014-09-18 |
JP2018062528A (ja) | 2018-04-19 |
KR20150126671A (ko) | 2015-11-12 |
EP2968253A4 (en) | 2016-11-02 |
JP6387389B2 (ja) | 2018-09-05 |
MX2015011783A (es) | 2015-12-01 |
NZ630367A (en) | 2017-02-24 |
EP2968253A1 (en) | 2016-01-20 |
IL240987A0 (en) | 2015-11-30 |
WO2014143613A1 (en) | 2014-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1219231A1 (zh) | 治療兒童實體瘤的方法 | |
HK1216991A1 (zh) | 癌疫苗及使用其的治療方法 | |
HK1220110A1 (zh) | 治療肺癌的方法 | |
HUE057061T2 (hu) | Kombinációs terápia rák kezelésére | |
SG10201801965RA (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
ZA201507733B (en) | Treatment of cancer with dihydropyrazino-pyrazines | |
HK1213817A1 (zh) | 治療癌症的方法 | |
EP3007756A4 (en) | Catheter-assisted tumor treatment | |
HK1205254A1 (zh) | 治療癌症的方法 | |
EP3008212A4 (en) | Methods of treatment of cancer | |
HK1219513A1 (zh) | 治療癌症的方法 | |
HK1223547A1 (zh) | 癌症治療方法 | |
IL241096A0 (en) | Treatment methods | |
GB201607581D0 (en) | Treatment of cancer | |
HK1232118A1 (zh) | 癌症的治療 | |
PL3016948T3 (pl) | 2-acyloaminotiazole do leczenia nowotworów | |
GB201322347D0 (en) | Treatment of cancer | |
GB201318742D0 (en) | Treatment of cancer | |
GB201308529D0 (en) | Treatment of cancer | |
GB201305020D0 (en) | Treatment of cancer | |
GB201322346D0 (en) | Combination treatment of cancer | |
GB201321628D0 (en) | Treatment of disease | |
GB201301685D0 (en) | Diagnosis and treatment of cancer | |
GB201322778D0 (en) | Method of treatment | |
GB201314882D0 (en) | Method of treatment |